ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Market Movers(Premarket)

View all
NasdaqNYSEAMEXOTCTSXEuronextLSE

NASDAQ Market Status

Advancing
331(42.17%)
Declining
340(43.31%)
Unchanged
114(14.52%)
  • % Gainers
  • % Losers
  • Most Active
TickerNamePriceChangeChange %Volume
AVTX LogoAVTXAvalo Therapeutics Inc18.3013.55285.26%138,275
BCG LogoBCGBinah Capital Group Inc21.0011.50121.05%10,724
SSKN LogoSSKNStrata Skin Sciences Inc0.660.215148.35%2
PIK LogoPIKKidpik Corporation4.190.9228.13%25,769
AKBA LogoAKBAAkebia Therapeutics Inc2.860.6227.68%736,432
LGVN LogoLGVNLongeveron Inc3.770.6621.22%653
SVMH LogoSVMHSRIVARU Holding Ltd0.31650.051519.43%16,793
MGIH LogoMGIHMillennium Group International Holdings Ltd1.510.2418.90%396
BRKH LogoBRKHBurTech Acquisition Corporation13.002.0018.18%135
LFLY LogoLFLYLeafly Holdings Inc3.500.4715.51%1
XXII LogoXXII22nd Century Group Inc0.15080.019314.68%100,230
NCNA LogoNCNANuCana PLC0.2466-0.06005-19.58%9,581
UGRO LogoUGROUrban Gro Inc1.48-0.335-18.46%351
INO LogoINOInovio Pharmaceuticals Inc New10.65-2.38-18.27%31
ABTS LogoABTSAbits Group Ltd0.69-0.107-13.43%60,006
MGOL LogoMGOLMGO Global Inc0.3931-0.0559-12.45%736
MLKN LogoMLKNMillerKnoll Inc26.81-3.72-12.18%59
HKIT LogoHKITHitek Global Inc1.59-0.15-8.62%904
MDIA LogoMDIAMediaco Holding Inc0.57-0.0501-8.08%1
OBLG LogoOBLGOblong Inc0.1305-0.0113-7.97%9,883
EGOX LogoEGOXNext e GO NV0.031-0.0026-7.74%211,867
XELA LogoXELAExela Technologies Inc2.83-0.225-7.36%1
KTRA LogoKTRAKintara Therapeutics Inc0.10250.01314.53%821,361
AKBA LogoAKBAAkebia Therapeutics Inc2.860.6227.68%736,432
CISS LogoCISSC3is Inc0.036-0.0022-5.76%447,016
SQQQ LogoSQQQProShares UltraPro Short QQQ10.430.030.29%366,658
GMDA LogoGMDAGamida Cell Ltd0.0555-0.0037-6.25%268,514
EGOX LogoEGOXNext e GO NV0.031-0.0026-7.74%211,867
VERB LogoVERBVerb Technology Company Inc0.2773-0.0037-1.32%159,663
AVTX LogoAVTXAvalo Therapeutics Inc18.3013.55285.26%138,275
NKLA LogoNKLANikola Corporation0.91450.00540.59%102,230
XXII LogoXXII22nd Century Group Inc0.15080.019314.68%100,230
TQQQ LogoTQQQProShares UltraPro QQQ61.87-0.08-0.13%84,515
TradesView all

Big Movers

12:02
Business Wire

Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.

00:26
PR Newswire (US)

Once-Daily Oral HIF-PH Inhibitor Activates Physiologic Response to Manage Anemia  Akebia's Launch Strategy Developed to Drive Toward a Potential New Oral Standard of Care Company to Host Conference Call on Thursday, March 28 at 8:00 AM ET CAMBRIDGE, Mass., March 27, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo® (vadadustat) Tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at ...

22:28
PR Newswire (US)

PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.

13:00
PR Newswire (US)

SAN DIEGO, March 27, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced the expansion of the inclusion criteria in the open label 15- patient REM-001 study in cutaneous metastatic breast cancer (CMBC) to include patients receiving pembrolizumab (KEYTRUDA®) for at least three months at screening.

Ticker Buzz Cloud
What is the Buzz Cloud?
  • The Buzz Cloud keeps track of how often tickers are mentioned to indicate the "level of buzz".
  • The larger the text, the more often the ticker is mentioned by the community.
  • You can use this page to spot trading opportunities based on the increase or decrease in the level of buzz.

Unlock more advanced trading tools

Join ADVFN today

Top Cryptocurrencies

View All Cryptos
Crypto Market Status
Advancing
9356(35%)
Declining
2365(8%)
Unchanged
14627(57%)
Ticker Name Price Change Change % Market Cap Volume
BTCBitcoin70,621.351,156.781.67%1.38T7,376,737,190
ETHEthereum3,575.1975.132.15%429.25B3,937,733,128
USDTTether USD0.999610.000170.02%97.81B1,037,898,827
BNBBinance Coin589.6315.512.70%93.01B517,323,115
SOLSolana187.901.740.93%82.44B1,821,036,200

Economic Calendar

This week's major US economic reports, Fed Speakers, indicators and market-moving events.
View full calendar